サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1567797

アジア太平洋のニキビ治療薬：2030年市場予測- 地域別分析- 治療クラス、剤形、タイプ、ニキビタイプ、流通チャネル別

Asia Pacific Acne Medication Market Forecast to 2030 - Regional Analysis - by Therapeutic Class, Formulation, Type, Acne Type, and Distribution Channel

出版日
ページ情報
英文 128 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
アジア太平洋のニキビ治療薬：2030年市場予測- 地域別分析- 治療クラス、剤形、タイプ、ニキビタイプ、流通チャネル別
出版日: 2024年08月07日
発行: The Insight Partners
ページ情報: 英文 128 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アジア太平洋のニキビ治療薬市場は、2022年に15億826万米ドルと評価され、2030年には26億7,290万米ドルに達すると予測され、2023年から2030年までのCAGRは7.4%と推定されます。

新薬の発売がアジア太平洋のニキビ治療薬市場を後押し

外用薬や全身用薬などの革新的な医薬品開発により、ニキビの治療アプローチが根本的に見直されています。2024年、オーストラリア医薬品庁（TGA）は、12歳以上の尋常性ざ瘡（ニキビ）治療薬としてインドのサンファーマシューティカル社のWinlevi（クラスコテロン）クリーム1%を承認しました。2022年、サン・ファーマシューティカル・インダストリーズ社は、カシオペア社とのニキビ治療に関する提携の範囲を拡大しました。WINLEVI（クラスコテロン）クリーム1％のライセンス契約と供給契約の延長契約を締結し、地理的範囲をオーストラリア、ニュージーランド、日本、ブラジル、メキシコ、ロシアに拡大しました。2023年、鳥居薬品株式会社は、免疫炎症性疾患の新規治療薬を創製する臨床段階のバイオテクノロジー企業であるノグラファーマ社と、尋常性ざ瘡治療薬NAC-GED-0507の日本における開発および商業化に関する導出契約を締結したと発表しました。

新薬の発売には、有効性の向上、安全性プロファイルの強化、副作用の低減を実現した先進的な製剤も含まれ、効果的なニキビ管理を求める人々の進化するニーズに対応しています。ボシュ・ヘルス・カンパニーズとその皮膚科事業であるオルト・デルマトロジックスが2023年10月に発表した声明によると、米国食品医薬品局（FDA）は、クリンダマイシンリン酸塩、アダパレン、過酸化ベンゾイルをそれぞれ1.2％、0.15％、3.1％配合したCABTREO外用ゲルの新薬承認申請を承認しました。本剤は12歳以上の尋常性ざ瘡を適応症とする外用治療薬です。CABTREOは、FDAによって承認された最初で唯一の3剤併用外用ニキビ治療薬であり、合剤で提供されます。同社は、2024年第1四半期にこのゲルを患者に提供することを目指しています。

レチノイド、抗アンドロゲン剤、免疫調整剤などの新規薬剤のイントロダクションより、ヘルスケア専門家やニキビに悩む患者が利用できる治療の選択肢はさらに広がっています。新薬の継続的な導入は競合を刺激し、技術革新を促進し、皮膚科医薬品業界における研究開発投資を促します。ニキビ治療のための個別化された標的治療アプローチへの注目の高まりは、患者の転帰と満足度を向上させる新薬登場の基盤を形成しています。このように、新薬の発売はアジア太平洋のニキビ治療薬市場の発展に大きく貢献しています。

アジア太平洋のニキビ治療薬市場の概要

アジア太平洋のニキビ治療薬市場は、中国、日本、インド、オーストラリア、韓国に区分されます。この地域は予測期間中に最も速いCAGRを記録すると予想されます。この地域で予測されるニキビ治療薬市場の成長は、新興国市場でのプレゼンス拡大に対する大手企業の関心の高まりとスキンケア産業の隆盛に起因しています。中国の可処分所得の増加は、スキンケアに対する消費者の支出を増加させ、ニキビ薬市場規模の拡大に寄与しています。ライフスタイルの変化や環境要因との関連も考えられるが、ニキビの有病率の増加が、効果的な治療に対する需要をさらに高めています。中国の消費者が健康のためにスキンケアを優先する中、製薬会社はこの急増する需要に対応するために革新的な製剤を導入しています。このように、先端技術、経済的要因、ヘルスケアの優先順位の進化が相俟って、中国のニキビ治療薬市場はかつてない成長へと舵を切っています。

アジア太平洋のニキビ治療薬市場の収益と2030年までの予測（金額）

アジア太平洋のニキビ治療薬市場のセグメンテーション

アジア太平洋のニキビ治療薬市場は、治療クラス、製剤、タイプ、ニキビタイプ、流通チャネル、国によって区分されます。

治療クラスに基づき、アジア太平洋のニキビ治療薬市場はレチノイド、過酸化ベンゾイル、抗生物質、サリチル酸、その他に区分されます。2022年にはレチノイドセグメントが最大のシェアを占めています。

製剤面では、アジア太平洋のニキビ治療薬市場は外用薬と内服薬に二分されます。外用薬セグメントは2022年に最大のシェアを占めました。

タイプ別では、アジア太平洋のニキビ治療薬市場は処方薬と市販薬に二分されます。2022年には、処方薬セグメントがより大きな最大シェアを占めました。

ニキビタイプ別に見ると、アジア太平洋のニキビ治療薬市場は非炎症性ニキビと炎症性ニキビに二分されます。2022年には炎症性ざ瘡セグメントがより大きなシェアを占めています。

流通チャネルの面では、アジア太平洋のニキビ治療薬市場は薬局・薬店、小売店、eコマースに区分されます。薬局・薬店セグメントが2022年に最も大きなシェアを占めました。

国別では、アジア太平洋のニキビ薬市場はオーストラリア、中国、インド、日本、韓国、その他アジア太平洋に分類されます。2022年のアジア太平洋のニキビ治療薬市場は中国が支配的でした。

Sun Pharmaceutical Industries Ltd、Teva Pharmaceutical Industries Ltd、Mayne Pharma Group Ltd、Almirall SA、Johnson &Johnson、Bausch Health Companies Inc、Galderma SA、Pfizer Inc、GSK Plc、Viatris Incは、アジア太平洋のニキビ薬市場で事業を展開している主要企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 アジア太平洋のニキビ治療薬市場情勢

  • PEST分析
  • 外用薬と経口薬の価格分析
  • ニキビ治療を受ける患者層

第5章 アジア太平洋のニキビ治療薬市場：主要市場力学

  • アジア太平洋のニキビ治療薬市場- 主要市場力学
  • 主要市場促進要因
    • 重症ニキビの有病率の増加
    • 新薬の発売
  • 主な市場抑制要因
    • ニキビ治療薬に伴う副作用
  • 主な市場機会
    • 最先端技術とデータ主導型戦略に基づく個別化治療プログラム
  • 今後の動向
    • オーガニック・ナチュラル治療へのニーズの高まり
  • 促進要因と抑制要因の影響

第6章 ニキビ治療薬市場：アジア太平洋市場分析

第7章 アジア太平洋のニキビ治療薬市場分析-治療クラス別

  • レチノイド
  • 過酸化ベンゾイル
  • 抗生物質
  • サリチル酸
  • その他

第8章 アジア太平洋のニキビ治療薬市場分析-剤形別

  • 外用薬
  • 経口薬

第9章 アジア太平洋のニキビ治療薬市場分析-タイプ別

  • 処方薬
  • 市販薬

第10章 アジア太平洋のニキビ治療薬市場分析-ニキビタイプ別

  • 非炎症性ニキビ
  • 炎症性ニキビ

第11章 アジア太平洋のニキビ治療薬市場分析-流通チャネル別

  • 薬局・ドラッグストア
  • 小売店
  • eコマース

第12章 アジア太平洋のニキビ治療薬市場：国別分析

  • アジア太平洋
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国
    • その他アジア太平洋

第13章 ニキビ治療薬市場：業界情勢

  • ニキビ治療薬市場の成長戦略
  • 有機的成長戦略
  • 無機的成長戦略
  • ファルマピエルと他社ニキビ治療薬の製品比較

第14章 企業プロファイル

  • Teva Pharmaceutical Industries Ltd
  • Mayne Pharma Group Ltd
  • Almirall SA
  • Johnson & Johnson
  • Sun Pharmaceutical Industries Ltd
  • Bausch Health Companies Inc
  • Galderma SA
  • Pfizer Inc
  • GSK Plc
  • Viatris Inc

第15章 付録

図表

List Of Tables

  • Table 1. Asia Pacific Acne Medication Market Segmentation
  • Table 2. Topical Medication
  • Table 3. Oral Medication
  • Table 4. Patient Population undergoing Acne Treatment from 2020-2023
  • Table 5. Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million) - by Therapeutic Class
  • Table 6. Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million) - by Formulation
  • Table 7. Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million) - by Type
  • Table 8. Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million) - by Acne Type
  • Table 9. Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
  • Table 10. Asia Pacific: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Country
  • Table 11. China: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
  • Table 12. China: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
  • Table 13. China: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 14. China: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
  • Table 15. China: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 16. Japan: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
  • Table 17. Japan: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
  • Table 18. Japan: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 19. Japan: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
  • Table 20. Japan: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 21. India: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
  • Table 22. India: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
  • Table 23. India: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 24. India: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
  • Table 25. India: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 26. Australia: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
  • Table 27. Australia: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
  • Table 28. Australia: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 29. Australia: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
  • Table 30. Australia: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 31. South Korea: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
  • Table 32. South Korea: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
  • Table 33. South Korea: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 34. South Korea: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
  • Table 35. South Korea: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 36. Rest of Asia Pacific: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
  • Table 37. Rest of Asia Pacific: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
  • Table 38. Rest of Asia Pacific: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 39. Rest of Asia Pacific: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
  • Table 40. Rest of Asia Pacific: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 41. Recent Organic Growth Strategies in Acne Medication Market
  • Table 42. Recent Inorganic Growth Strategies in the Acne Medication Market
  • Table 43. Glossary of Terms, Acne Medication Market

List Of Figures

  • Figure 1. Asia Pacific Acne Medication Market Segmentation, by Country
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Asia Pacific Acne Medication Market Revenue (US$ Million), 2022-2030
  • Figure 5. Asia Pacific Acne Medication Market Share (%) - by Therapeutic Class (2022 and 2030)
  • Figure 6. Retinoids: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Benzoyl Peroxide: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Antibiotics: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Salicylic Acid: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Others: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Asia Pacific Acne Medication Market Share (%) - by Formulation (2022 and 2030)
  • Figure 12. Topical Medication: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Oral Medication: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Asia Pacific Acne Medication Market Share (%) - by Type (2022 and 2030)
  • Figure 15. Prescription Medicine: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Over-the-Counter Medicine: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Asia Pacific Acne Medication Market Share (%) - by Acne Type (2022 and 2030)
  • Figure 18. Non-Inflammatory Acne: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Inflammatory Acne: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Asia Pacific Acne Medication Market Share (%) - by Distribution Channel (2022 and 2030)
  • Figure 21. Pharmacies and Drug Stores: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Retail Stores: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. E-Commerce: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Asia Pacific: Acne Medication Market - Country, 2022 (US$ Million)
  • Figure 25. Asia Pacific: Acne Medication Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 26. China: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 27. Japan: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 28. India: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 29. Australia: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 30. South Korea: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 31. Rest of Asia Pacific: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 32. Growth Strategies in Acne Medication Market
目次
Product Code: BMIRE00030658

The Asia Pacific acne medication market was valued at US$ 1,508.26 in 2022 and is expected to reach US$ 2,672.90 million by 2030; it is estimated to register at a CAGR of 7.4% from 2023 to 2030.

Launch of Novel Drugs Boosts Asia Pacific Acne Medication Market

Innovative pharmaceutical developments, including topical and systemic medications, have fundamentally reshaped treatment approaches for acne. In 2024, the Australian Therapeutic Goods Administration (TGA) approved Winlevi (clascoterone) cream 1% from Sun Pharmaceutical of India to treat acne vulgaris in individuals 12 years of age and older. In 2022, Sun Pharmaceutical Industries broadened the scope of its collaboration with Cassiopea with respect to an acne treatment. It has signed extension agreements to the license and supply contracts for WINLEVI (clascoterone) cream 1 percent, enlarging the geographical scope to encompass Australia, New Zealand, Japan, Brazil, Mexico, and Russia. In 2023, Torii Pharmaceutical Co., Ltd. and Nogra Pharma, a clinical-stage biotechnology company creating novel therapeutics for immune-inflammatory-mediated diseases, announced an out-licensing agreement for the development and commercialization of NAC-GED-0507 for the treatment of acne vulgaris in Japan.

Novel drug launches also include advanced formulations with improved efficacy, enhanced safety profiles, and reduced side effects, catering to the evolving needs of individuals seeking effective acne management. According to a statement released in October 2023 by Bausch Health Companies Inc. and its dermatology business-Ortho Dermatologics-the US Food and Drug Administration (FDA) approved the New Drug Application for CABTREO topical gel composed of 1.2%, 0.15%, and 3.1% clindamycin phosphate, adapalene, and benzoyl peroxide, respectively. This is a topical treatment indicated for acne vulgaris in patients aged 12 or older. CABTREO is the first and only topical triple combination acne therapy approved by the FDA, which is offered in a fixed-dose form. The company aims to make this gel available for patients in Q1 2024.

The introduction of novel medications, such as retinoids, anti-androgens, and immune modulators, has further expanded the therapeutic options available for healthcare professionals and individuals dealing with acne. The continuous introduction of new drugs stimulates competition, fosters innovation, and encourages research and development investments within the dermatological pharmaceutical industry. The heightened focus on personalized and targeted treatment approaches for treating acne forms a foundation for the advent of novel drugs to improve patient outcomes and satisfaction. Thus, the launch of novel drugs significantly contributes to the progress of the Asia Pacific acne medication market.

Asia Pacific Acne Medication Market Overview

The Asia Pacific acne medication market is segmented into China, Japan, India, Australia, and South Korea. This region is expected to record the fastest CAGR during the forecast period. The projected acne medication market growth in the region is ascribed to the burgeoning interest of major players in expanding their presence in developing regions and the flourishment of the skincare industry. China's nation's rising disposable income has heightened consumer spending on skincare, contributing to the expansion of the acne medication market size. The increased prevalence of acne, possibly linked to lifestyle changes and environmental factors, has further fueled demand for effective treatments. As Chinese consumers prioritize skincare for their well-being, pharmaceutical companies are introducing innovative formulations to meet this burgeoning demand. Thus, advanced technologies, economic factors, and evolving healthcare priorities are together steering the acne medication market toward unprecedented growth in China.

Asia Pacific Acne Medication Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Acne Medication Market Segmentation

The Asia Pacific acne medication market is segmented based on therapeutic class, formulation, type, acne type, distribution channel, and country.

Based on therapeutic class, the Asia Pacific acne medication market is segmented into retinoids, benzoyl peroxide, antibiotics, salicylic acid, and others. The retinoids segment held the largest share in 2022.

In terms of formulation, the Asia Pacific acne medication market is bifurcated into topical medication and oral medication. The topical medication segment held a larger largest share in 2022.

By type, the Asia Pacific acne medication market is bifurcated into prescription medicine and over-the-counter medicine. The prescription medicine segment held a larger largest share in 2022.

Based on acne type, the Asia Pacific acne medication market is bifurcated into non-inflammatory acne and inflammatory acne. The inflammatory acne segment held a larger share in 2022.

In terms of distribution channel, the Asia Pacific acne medication market is segmented into pharmacies and drug stores, retail stores, and e-commerce. The pharmacies and drug stores segment held the largest share in 2022.

Based on country, the Asia Pacific acne medication market is categorized into Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific acne medication market in 2022.

Sun Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd, Mayne Pharma Group Ltd, Almirall SA, Johnson & Johnson, Bausch Health Companies Inc, Galderma SA, Pfizer Inc, GSK Plc, and Viatris Inc are some of the leading companies operating in the Asia Pacific acne medication market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Acne Medication Market Landscape

  • 4.1 PEST Analysis
  • 4.2 Pricing Analysis of Topical and Oral Medication
  • 4.3 Patient Population Undergoing Acne Treatment

5. Asia Pacific Acne Medication Market - Key Market Dynamics

  • 5.1 Asia Pacific Acne Medication Market - Key Market Dynamics
  • 5.2 Key Market Drivers
    • 5.2.1 Increasing Prevalence of Severe Acne
    • 5.2.2 Launch of Novel Drugs
  • 5.3 Key Market Restraints
    • 5.3.1 Side Effects Associated with Acne Medication
  • 5.4 Key Market Opportunities
    • 5.4.1 Individualized Treatment Programs Based on Cutting-Edge Technologies and Data-Driven Strategies
  • 5.5 Future Trends
    • 5.5.1 Upsurge in Need for Organic and Natural Treatments
  • 5.6 Impact of Drivers and Restraints:

6. Acne Medication Market - Asia Pacific Market Analysis

7. Asia Pacific Acne Medication Market Analysis - by Therapeutic Class

  • 7.1 Retinoids
    • 7.1.1 Overview
    • 7.1.2 Retinoids: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.2 Benzoyl Peroxide
    • 7.2.1 Overview
    • 7.2.2 Benzoyl Peroxide: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Antibiotics
    • 7.3.1 Overview
    • 7.3.2 Antibiotics: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Salicylic Acid
    • 7.4.1 Overview
    • 7.4.2 Salicylic Acid: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Others
    • 7.5.1 Overview
    • 7.5.2 Others: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Acne Medication Market Analysis - by Formulation

  • 8.1 Topical Medication
    • 8.1.1 Overview
    • 8.1.2 Topical Medication: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.2 Oral Medication
    • 8.2.1 Overview
    • 8.2.2 Oral Medication: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Acne Medication Market Analysis - by Type

  • 9.1 Prescription Medicine
    • 9.1.1 Overview
    • 9.1.2 Prescription Medicine: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.2 Over-the-Counter Medicine
    • 9.2.1 Overview
    • 9.2.2 Over-the-Counter Medicine: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Acne Medication Market Analysis - by Acne Type

  • 10.1 Non-Inflammatory Acne
    • 10.1.1 Overview
    • 10.1.2 Non-Inflammatory Acne: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.2 Inflammatory Acne
    • 10.2.1 Overview
    • 10.2.2 Inflammatory Acne: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

11. Asia Pacific Acne Medication Market Analysis - by Distribution Channel

  • 11.1 Pharmacies and Drug Stores
    • 11.1.1 Overview
    • 11.1.2 Pharmacies and Drug Stores: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • 11.2 Retail Stores
    • 11.2.1 Overview
    • 11.2.2 Retail Stores: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • 11.3 E-Commerce
    • 11.3.1 Overview
    • 11.3.2 E-Commerce: Asia Pacific Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

12. Asia Pacific Acne Medication Market - Country Analysis

  • 12.1 Asia Pacific
    • 12.1.1 Asia Pacific: Acne Medication Market - Revenue and Forecast Analysis - by Country
      • 12.1.1.1 Asia Pacific: Acne Medication Market - Revenue and Forecast Analysis - by Country
      • 12.1.1.2 China
      • 12.1.1.3 China: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.1.1.3.1 China: Acne Medication Market Breakdown, by Therapeutic Class
        • 12.1.1.3.2 China: Acne Medication Market Breakdown, by Formulation
        • 12.1.1.3.3 China: Acne Medication Market Breakdown, by Type
        • 12.1.1.3.4 China: Acne Medication Market Breakdown, by Acne Type
        • 12.1.1.3.5 China: Acne Medication Market Breakdown, by Distribution Channel
      • 12.1.1.4 Japan
      • 12.1.1.5 Japan: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.1.1.5.1 Japan: Acne Medication Market Breakdown, by Therapeutic Class
        • 12.1.1.5.2 Japan: Acne Medication Market Breakdown, by Formulation
        • 12.1.1.5.3 Japan: Acne Medication Market Breakdown, by Type
        • 12.1.1.5.4 Japan: Acne Medication Market Breakdown, by Acne Type
        • 12.1.1.5.5 Japan: Acne Medication Market Breakdown, by Distribution Channel
      • 12.1.1.6 India
      • 12.1.1.7 India: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.1.1.7.1 India: Acne Medication Market Breakdown, by Therapeutic Class
        • 12.1.1.7.2 India: Acne Medication Market Breakdown, by Formulation
        • 12.1.1.7.3 India: Acne Medication Market Breakdown, by Type
        • 12.1.1.7.4 India: Acne Medication Market Breakdown, by Acne Type
        • 12.1.1.7.5 India: Acne Medication Market Breakdown, by Distribution Channel
      • 12.1.1.8 Australia
      • 12.1.1.9 Australia: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.1.1.9.1 Australia: Acne Medication Market Breakdown, by Therapeutic Class
        • 12.1.1.9.2 Australia: Acne Medication Market Breakdown, by Formulation
        • 12.1.1.9.3 Australia: Acne Medication Market Breakdown, by Type
        • 12.1.1.9.4 Australia: Acne Medication Market Breakdown, by Acne Type
        • 12.1.1.9.5 Australia: Acne Medication Market Breakdown, by Distribution Channel
      • 12.1.1.10 South Korea
      • 12.1.1.11 South Korea: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.1.1.11.1 South Korea: Acne Medication Market Breakdown, by Therapeutic Class
        • 12.1.1.11.2 South Korea: Acne Medication Market Breakdown, by Formulation
        • 12.1.1.11.3 South Korea: Acne Medication Market Breakdown, by Type
        • 12.1.1.11.4 South Korea: Acne Medication Market Breakdown, by Acne Type
        • 12.1.1.11.5 South Korea: Acne Medication Market Breakdown, by Distribution Channel
      • 12.1.1.12 Rest of Asia Pacific
      • 12.1.1.13 Rest of Asia Pacific: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.1.1.13.1 Rest of Asia Pacific: Acne Medication Market Breakdown, by Therapeutic Class
        • 12.1.1.13.2 Rest of Asia Pacific: Acne Medication Market Breakdown, by Formulation
        • 12.1.1.13.3 Rest of Asia Pacific: Acne Medication Market Breakdown, by Type
        • 12.1.1.13.4 Rest of Asia Pacific: Acne Medication Market Breakdown, by Acne Type
        • 12.1.1.13.5 Rest of Asia Pacific: Acne Medication Market Breakdown, by Distribution Channel

13. Acne Medication Market- Industry Landscape

  • 13.1 Overview
  • 13.2 Growth Strategies in Acne Medication Market
  • 13.3 Organic Growth Strategies
    • 13.3.1 Overview
  • 13.4 Inorganic Growth Strategies
    • 13.4.1 Overview
  • 13.5 Product Offered by Farmapiel vs Other Companies Acne Products

14. Company Profiles

  • 14.1 Teva Pharmaceutical Industries Ltd
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Mayne Pharma Group Ltd
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 Almirall SA
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Johnson & Johnson
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 Sun Pharmaceutical Industries Ltd
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 Bausch Health Companies Inc
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 Galderma SA
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments
  • 14.8 Pfizer Inc
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments
  • 14.9 GSK Plc
    • 14.9.1 Key Facts
    • 14.9.2 Business Description
    • 14.9.3 Products and Services
    • 14.9.4 Financial Overview
    • 14.9.5 SWOT Analysis
    • 14.9.6 Key Developments
  • 14.10 Viatris Inc
    • 14.10.1 Key Facts
    • 14.10.2 Business Description
    • 14.10.3 Products and Services
    • 14.10.4 Financial Overview
    • 14.10.5 SWOT Analysis
    • 14.10.6 Key Developments

15. Appendix

  • 15.1 About The Insight Partners
  • 15.2 Glossary of Terms